• 1
    Valla D, Poynard T, Bercoff E, Bataille C, Goldfarb G, Lebrec D. Le syndrome d'hypercinésie circulatoire systémique chez les malades atteints de cirrhose. Gastroenterol Clin Biol 1984; 8:321324.MEDLINE
  • 2
    Ma Z, Lee SS. Cirrhotic cardiomyopathy: getting to the heart of the matter. Hepatology 1996; 24:451459.MEDLINE
  • 3
    Kelbaek H, Eriksen J, Brynjolf I, Raboel A, Lund JO, Munck O, Bonnevie O, et al. Cardiac performance in patients with asymptomatic alcoholic cirrhosis of the liver. Am J Cardiol 1984; 54:852855.MEDLINE
  • 4
    Grose RD, Nolan J, Dillon JF, Errington M, Hannan WJ, Bouchier IAD, Hayes PC. Exercise-induced left ventricular dysfunction in alcoholic and non-alcoholic cirrhosis. J Hepatol 1995; 22:326332.MEDLINE
  • 5
    Adams JE, Bodor GS, Davila-Roman VG, Delmez JA, Apple FS, Ladenson JH. Cardiac troponin I: a marker with high specificity for cardiac injury. Circulation 1993; 88:101106.MEDLINE
  • 6
    Nairn AC, Perry SV. Calmodulin and myosin light-chain kinase of rabbit fast skeletal muscle. Biochem J 1979; 1:8997.
  • 7
    Bodor GS, Porter S, Landt Y, Ladenson JH. Development of monoclonal antibodies for an assay of cardiac troponin-I and preliminary results in suspected cases of myocardial infarction. Clin Chem 1992; 38:22032214.MEDLINE
  • 8
    Lebrec D. Methods to evaluate portal hypertension. Gastroenterol Clin North Am 1992; 21:4159.MEDLINE
  • 9
    Devereux R, Reichek N. Echographic determination of left ventricular mass in man. Circulation 1977; 55:613618.MEDLINE
  • 10
    Ossendorf M, Eberle B, Ehrenthal W, Rupprecht HJ, Mayer E, Kumpmann K, Hafner G, et al. Analytical and clinical evaluation of the access troponin I immunoassay. Clin Lab 1997; 43:627636.
  • 11
    Bodor GS, Porterfield D, Voss EM, Smith S, Apple FS. Cardiac troponin-I is not expressed in fetal and healthy or diseased adult human skeletal muscle tissue. Clin Chem 1995; 41:17101715.MEDLINE
  • 12
    Therapondos G, Plevris JN, Dollinger MM, Gulliver-Sloan FH, Flapan AD, Hayes PC. Subclinical myocardial damage in patients with liver cirrhosis prior to liver transplantation. J Hepatol 26(Suppl 1):17101715.
  • 13
    Larue C, Calzolari C, Bertinchant JP, Leclercq F, Grolleau R, Pau B. Cardiac-specific immunoenzymometric assay of troponin I in the early phase of acute myocardial infarction. Clin Chem 1993; 39:972979.MEDLINE
  • 14
    Apple F, Dahlmeier B, Sharkey S. Serum cardiac troponin I and T concentrations in end stage renal disease, type I diabetes patients. Clin Chem 41:972979.
  • 15
    Bodor GS. Cardiac troponin-I: a highly specific biochemical marker for myocardial infarction. J Clin Immunoassay 1994; 17:4044.
  • 16
    Antman EM, Tanasijevic MJ, Thompson B, Schactman M, McCabe CH, Cannon CP, Fischer GA, et al. Cardiac-specific troponin-I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996; 335:13421349.MEDLINE
  • 17
    Adams JE, Sicard GA, Allen BT, Bridwell KH, Lenke LG, Davila-Roman VG, Bodor GS, et al. Diagnosis of perioperative myocardial infarction with measurement of cardiac troponin I. N Engl J Med 1994; 330:670674.MEDLINE
  • 18
    Smith SC, Ladenson JH, Mason JW, Jaffe AS. Elevations of cardiac Troponin I associated with myocarditis. Circulation 1997; 95:163168.MEDLINE
  • 19
    Adams JE, Davila-Roman VG, Bessey PQ, Blake DP, Ladenson JH, Jaffe AS. Improved detection of cardiac contusion with cardiac troponin I. Am Heart J 1996; 131:308312.MEDLINE
  • 20
    Bertinchant JP, Larue C, Mair J, Calzolari C, Trinquier S, Paolucci F, Beck L, et al. Intérêt du dosage de la troponine I cardiaque humaine dans le diagnostic de l'infarctus aigu du myocarde. Immunoanal Biol Spec 1994; 9:353359.
  • 21
    Antman EM, Tanasijevic MJ, Cannon CP, Schactman M, McCabe CH, Fischer G, Wybenge D, et al. Cardiac troponin I on admission predicts death by 42 days in unstable angina and improved survival with an early invasive strategy: results from TIMI III B. Circulation 92:(Suppl 1):353359.
  • 22
    Lee SS. Cardiac abnormalities in liver cirrhosis. West J Med 1989; 151:530535.MEDLINE
  • 23
    Finucci G, Desideri A, Sacerdoti D, Bolognesi M, Merkel C, Angeli P, Gatta A, et al. Left ventricular diastolic function in liver cirrhosis. Scand J Gastroenterol 1996; 31:279284.MEDLINE
  • 24
    Keller H, Bezjak V, Stegaru B, Buss J, Holm E, Heene DL. Ventricular function in cirrhosis and portosystemic shunt: a two-dimensional echocardiographic study. Hepatology 1988; 3:658662.
  • 25
    Pearson TC, Henderson JM, DePuey G, Kutner M, Warren WD. Cardiac index and left ventricular function changes in cirrhosis measured by radionuclide angiocardiography. Dig Surg 1988; 5:151155.
  • 26
    Gaudin C, Braillon A, Poo JL, Moreau R, Hadengue A, Lebrec D. Regional sympathetic activity, severity of liver disease and hemodynamics in patients with cirrhosis. J Hepatol 1991; 13:161168.MEDLINE
  • 27
    Crozatier B. Stretch-induced modifications of myocardial performance: from ventricular function to cellular and molecular mechanisms. Cardiovasc Res 1996; 32:2527.MEDLINE
  • 28
    Caramelo C, Fernandes-Munoz D, Santos JC, Blanchart A, Rodriguez-Puyol D, Lopez-Novoa JM, Hernando L. Effect of volume expansion on hemodynamics, capillary permeability, and renal function in conscious cirrhotic rats. Hepatology 1986; 6:129134.MEDLINE
  • 29
    Pozzi M, Carugo S, Boari G, Pecci V, De Ceglia S, Maggiolini S, Bolla GB, et al. Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites. Hepatology 1997; 26:113117.MEDLINE
  • 30
    Grant WC, Wasserman F, Rodensky PL. The incidence of myocardial infarction in portal cirrhosis. Ann Intern Med 1959; 51:774779.
  • 31
    Missov E, Calzolari C, Pau B. Circulating cardiac troponin I in severe congestive heart failure. Circulation 1997; 96:29532958.MEDLINE